Pre-order Enquiry
Request Free Sample
Global Multiple Sclerosis (MS) Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
SKU ID : GIR-21191355 | Publishing Date : 03-Jul-2022 | No. of pages : 114
Detailed TOC of Global Multiple Sclerosis (MS) Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
1 Market Overview1.1 Multiple Sclerosis (MS) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Multiple Sclerosis (MS) Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Copaxone (Glatiramer Acetate, Copolymer 1)
1.2.3 Novantrone (Mitoxantrone)
1.2.4 Gilenya (Fingolimod, Fty720)
1.2.5 Aubagio (Teriflunomide)
1.2.6 Tecfidera (Dimethyl Fumarate)
1.2.7 Firategrast (Sb683699, T-0047)
1.2.8 Siponimod (Baf312)
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Multiple Sclerosis (MS) Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 RRMS
1.3.3 SPMS
1.3.4 PPMS
1.3.5 PRMS
1.4 Global Multiple Sclerosis (MS) Drugs Market Size & Forecast
1.4.1 Global Multiple Sclerosis (MS) Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Multiple Sclerosis (MS) Drugs Sales in Volume (2017-2028)
1.4.3 Global Multiple Sclerosis (MS) Drugs Price (2017-2028)
1.5 Global Multiple Sclerosis (MS) Drugs Production Capacity Analysis
1.5.1 Global Multiple Sclerosis (MS) Drugs Total Production Capacity (2017-2028)
1.5.2 Global Multiple Sclerosis (MS) Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Multiple Sclerosis (MS) Drugs Market Drivers
1.6.2 Multiple Sclerosis (MS) Drugs Market Restraints
1.6.3 Multiple Sclerosis (MS) Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Multiple Sclerosis (MS) Drugs Product and Services
2.1.4 Bayer AG Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayhill Therapeutics
2.2.1 Bayhill Therapeutics Details
2.2.2 Bayhill Therapeutics Major Business
2.2.3 Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Product and Services
2.2.4 Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biogen Idec
2.3.1 Biogen Idec Details
2.3.2 Biogen Idec Major Business
2.3.3 Biogen Idec Multiple Sclerosis (MS) Drugs Product and Services
2.3.4 Biogen Idec Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cinnagen
2.4.1 Cinnagen Details
2.4.2 Cinnagen Major Business
2.4.3 Cinnagen Multiple Sclerosis (MS) Drugs Product and Services
2.4.4 Cinnagen Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Multiple Sclerosis (MS) Drugs Product and Services
2.5.4 Daiichi Sankyo Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Multiple Sclerosis (MS) Drugs Product and Services
2.6.4 Eli Lilly Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Fast Forward Llc
2.7.1 Fast Forward Llc Details
2.7.2 Fast Forward Llc Major Business
2.7.3 Fast Forward Llc Multiple Sclerosis (MS) Drugs Product and Services
2.7.4 Fast Forward Llc Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Antisense Therapeutics
2.8.1 Antisense Therapeutics Details
2.8.2 Antisense Therapeutics Major Business
2.8.3 Antisense Therapeutics Multiple Sclerosis (MS) Drugs Product and Services
2.8.4 Antisense Therapeutics Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Apitope
2.9.1 Apitope Details
2.9.2 Apitope Major Business
2.9.3 Apitope Multiple Sclerosis (MS) Drugs Product and Services
2.9.4 Apitope Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Five Prime Therapeutics
2.10.1 Five Prime Therapeutics Details
2.10.2 Five Prime Therapeutics Major Business
2.10.3 Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Product and Services
2.10.4 Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Genmab
2.11.1 Genmab Details
2.11.2 Genmab Major Business
2.11.3 Genmab Multiple Sclerosis (MS) Drugs Product and Services
2.11.4 Genmab Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Artielle Immunotherapeutics
2.12.1 Artielle Immunotherapeutics Details
2.12.2 Artielle Immunotherapeutics Major Business
2.12.3 Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Product and Services
2.12.4 Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Genzyme
2.13.1 Genzyme Details
2.13.2 Genzyme Major Business
2.13.3 Genzyme Multiple Sclerosis (MS) Drugs Product and Services
2.13.4 Genzyme Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Glaxosmithkline
2.14.1 Glaxosmithkline Details
2.14.2 Glaxosmithkline Major Business
2.14.3 Glaxosmithkline Multiple Sclerosis (MS) Drugs Product and Services
2.14.4 Glaxosmithkline Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Gw Pharmaceuticals
2.15.1 Gw Pharmaceuticals Details
2.15.2 Gw Pharmaceuticals Major Business
2.15.3 Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Product and Services
2.15.4 Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Innate Immunotherapeutics
2.16.1 Innate Immunotherapeutics Details
2.16.2 Innate Immunotherapeutics Major Business
2.16.3 Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Product and Services
2.16.4 Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Multiple Sclerosis (MS) Drugs Breakdown Data by Manufacturer
3.1 Global Multiple Sclerosis (MS) Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Multiple Sclerosis (MS) Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Multiple Sclerosis (MS) Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Multiple Sclerosis (MS) Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Multiple Sclerosis (MS) Drugs Manufacturer Market Share in 2021
3.5 Global Multiple Sclerosis (MS) Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Multiple Sclerosis (MS) Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Multiple Sclerosis (MS) Drugs Market Size by Region
4.1.1 Global Multiple Sclerosis (MS) Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Multiple Sclerosis (MS) Drugs Revenue by Region (2017-2028)
4.2 North America Multiple Sclerosis (MS) Drugs Revenue (2017-2028)
4.3 Europe Multiple Sclerosis (MS) Drugs Revenue (2017-2028)
4.4 Asia-Pacific Multiple Sclerosis (MS) Drugs Revenue (2017-2028)
4.5 South America Multiple Sclerosis (MS) Drugs Revenue (2017-2028)
4.6 Middle East and Africa Multiple Sclerosis (MS) Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Multiple Sclerosis (MS) Drugs Sales in Volume by Type (2017-2028)
5.2 Global Multiple Sclerosis (MS) Drugs Revenue by Type (2017-2028)
5.3 Global Multiple Sclerosis (MS) Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Multiple Sclerosis (MS) Drugs Sales in Volume by Application (2017-2028)
6.2 Global Multiple Sclerosis (MS) Drugs Revenue by Application (2017-2028)
6.3 Global Multiple Sclerosis (MS) Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Multiple Sclerosis (MS) Drugs Sales by Type (2017-2028)
7.2 North America Multiple Sclerosis (MS) Drugs Sales by Application (2017-2028)
7.3 North America Multiple Sclerosis (MS) Drugs Market Size by Country
7.3.1 North America Multiple Sclerosis (MS) Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Multiple Sclerosis (MS) Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Multiple Sclerosis (MS) Drugs Sales by Type (2017-2028)
8.2 Europe Multiple Sclerosis (MS) Drugs Sales by Application (2017-2028)
8.3 Europe Multiple Sclerosis (MS) Drugs Market Size by Country
8.3.1 Europe Multiple Sclerosis (MS) Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Multiple Sclerosis (MS) Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Multiple Sclerosis (MS) Drugs Market Size by Region
9.3.1 Asia-Pacific Multiple Sclerosis (MS) Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Multiple Sclerosis (MS) Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Multiple Sclerosis (MS) Drugs Sales by Type (2017-2028)
10.2 South America Multiple Sclerosis (MS) Drugs Sales by Application (2017-2028)
10.3 South America Multiple Sclerosis (MS) Drugs Market Size by Country
10.3.1 South America Multiple Sclerosis (MS) Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Multiple Sclerosis (MS) Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Multiple Sclerosis (MS) Drugs Market Size by Country
11.3.1 Middle East & Africa Multiple Sclerosis (MS) Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Multiple Sclerosis (MS) Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Multiple Sclerosis (MS) Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Multiple Sclerosis (MS) Drugs
12.3 Multiple Sclerosis (MS) Drugs Production Process
12.4 Multiple Sclerosis (MS) Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Multiple Sclerosis (MS) Drugs Typical Distributors
13.3 Multiple Sclerosis (MS) Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Multiple Sclerosis (MS) Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
List of TablesTable 1. Global Multiple Sclerosis (MS) Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Multiple Sclerosis (MS) Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Multiple Sclerosis (MS) Drugs Product and Services
Table 6. Bayer AG Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bayhill Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Bayhill Therapeutics Major Business
Table 9. Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Product and Services
Table 10. Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 12. Biogen Idec Major Business
Table 13. Biogen Idec Multiple Sclerosis (MS) Drugs Product and Services
Table 14. Biogen Idec Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cinnagen Basic Information, Manufacturing Base and Competitors
Table 16. Cinnagen Major Business
Table 17. Cinnagen Multiple Sclerosis (MS) Drugs Product and Services
Table 18. Cinnagen Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Major Business
Table 21. Daiichi Sankyo Multiple Sclerosis (MS) Drugs Product and Services
Table 22. Daiichi Sankyo Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly Multiple Sclerosis (MS) Drugs Product and Services
Table 26. Eli Lilly Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Fast Forward Llc Basic Information, Manufacturing Base and Competitors
Table 28. Fast Forward Llc Major Business
Table 29. Fast Forward Llc Multiple Sclerosis (MS) Drugs Product and Services
Table 30. Fast Forward Llc Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Antisense Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Antisense Therapeutics Major Business
Table 33. Antisense Therapeutics Multiple Sclerosis (MS) Drugs Product and Services
Table 34. Antisense Therapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Apitope Basic Information, Manufacturing Base and Competitors
Table 36. Apitope Major Business
Table 37. Apitope Multiple Sclerosis (MS) Drugs Product and Services
Table 38. Apitope Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Five Prime Therapeutics Basic Information, Manufacturing Base and Competitors
Table 40. Five Prime Therapeutics Major Business
Table 41. Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Product and Services
Table 42. Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Genmab Basic Information, Manufacturing Base and Competitors
Table 44. Genmab Major Business
Table 45. Genmab Multiple Sclerosis (MS) Drugs Product and Services
Table 46. Genmab Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Artielle Immunotherapeutics Basic Information, Manufacturing Base and Competitors
Table 48. Artielle Immunotherapeutics Major Business
Table 49. Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Product and Services
Table 50. Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Genzyme Basic Information, Manufacturing Base and Competitors
Table 52. Genzyme Major Business
Table 53. Genzyme Multiple Sclerosis (MS) Drugs Product and Services
Table 54. Genzyme Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 56. Glaxosmithkline Major Business
Table 57. Glaxosmithkline Multiple Sclerosis (MS) Drugs Product and Services
Table 58. Glaxosmithkline Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Gw Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Gw Pharmaceuticals Major Business
Table 61. Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Product and Services
Table 62. Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Innate Immunotherapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Innate Immunotherapeutics Major Business
Table 65. Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Product and Services
Table 66. Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Multiple Sclerosis (MS) Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 68. Global Multiple Sclerosis (MS) Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Multiple Sclerosis (MS) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Multiple Sclerosis (MS) Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 71. Head Office and Multiple Sclerosis (MS) Drugs Production Site of Key Manufacturer
Table 72. Multiple Sclerosis (MS) Drugs New Entrant and Capacity Expansion Plans
Table 73. Multiple Sclerosis (MS) Drugs Mergers & Acquisitions in the Past Five Years
Table 74. Global Multiple Sclerosis (MS) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 75. Global Multiple Sclerosis (MS) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 76. Global Multiple Sclerosis (MS) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Multiple Sclerosis (MS) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Multiple Sclerosis (MS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 79. Global Multiple Sclerosis (MS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 80. Global Multiple Sclerosis (MS) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Multiple Sclerosis (MS) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Multiple Sclerosis (MS) Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 83. Global Multiple Sclerosis (MS) Drugs Price by Type (2023-2028) & (USD/Pcs)
Table 84. Global Multiple Sclerosis (MS) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 85. Global Multiple Sclerosis (MS) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 86. Global Multiple Sclerosis (MS) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Multiple Sclerosis (MS) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Multiple Sclerosis (MS) Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 89. Global Multiple Sclerosis (MS) Drugs Price by Application (2023-2028) & (USD/Pcs)
Table 90. North America Multiple Sclerosis (MS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 91. North America Multiple Sclerosis (MS) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 92. North America Multiple Sclerosis (MS) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Multiple Sclerosis (MS) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Multiple Sclerosis (MS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 95. North America Multiple Sclerosis (MS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 96. North America Multiple Sclerosis (MS) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 97. North America Multiple Sclerosis (MS) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 98. Europe Multiple Sclerosis (MS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 99. Europe Multiple Sclerosis (MS) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 100. Europe Multiple Sclerosis (MS) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Multiple Sclerosis (MS) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Multiple Sclerosis (MS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 103. Europe Multiple Sclerosis (MS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 104. Europe Multiple Sclerosis (MS) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 105. Europe Multiple Sclerosis (MS) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 106. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 107. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 108. Asia-Pacific Multiple Sclerosis (MS) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Multiple Sclerosis (MS) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 111. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 112. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 113. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 114. South America Multiple Sclerosis (MS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 115. South America Multiple Sclerosis (MS) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 116. South America Multiple Sclerosis (MS) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Multiple Sclerosis (MS) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Multiple Sclerosis (MS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 119. South America Multiple Sclerosis (MS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 120. South America Multiple Sclerosis (MS) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 121. South America Multiple Sclerosis (MS) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 122. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 123. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 124. Middle East & Africa Multiple Sclerosis (MS) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Multiple Sclerosis (MS) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 127. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 128. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 129. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 130. Multiple Sclerosis (MS) Drugs Raw Material
Table 131. Key Manufacturers of Multiple Sclerosis (MS) Drugs Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Multiple Sclerosis (MS) Drugs Typical Distributors
Table 135. Multiple Sclerosis (MS) Drugs Typical Customers
List of Figures
Figure 1. Multiple Sclerosis (MS) Drugs Picture
Figure 2. Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Type in 2021
Figure 3. Copaxone (Glatiramer Acetate, Copolymer 1)
Figure 4. Novantrone (Mitoxantrone)
Figure 5. Gilenya (Fingolimod, Fty720)
Figure 6. Aubagio (Teriflunomide)
Figure 7. Tecfidera (Dimethyl Fumarate)
Figure 8. Firategrast (Sb683699, T-0047)
Figure 9. Siponimod (Baf312)
Figure 10. Others
Figure 11. Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Application in 2021
Figure 12. RRMS
Figure 13. SPMS
Figure 14. PPMS
Figure 15. PRMS
Figure 16. Global Multiple Sclerosis (MS) Drugs Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 17. Global Multiple Sclerosis (MS) Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Multiple Sclerosis (MS) Drugs Sales (2017-2028) & (K Pcs)
Figure 19. Global Multiple Sclerosis (MS) Drugs Price (2017-2028) & (USD/Pcs)
Figure 20. Global Multiple Sclerosis (MS) Drugs Production Capacity (2017-2028) & (K Pcs)
Figure 21. Global Multiple Sclerosis (MS) Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Multiple Sclerosis (MS) Drugs Market Drivers
Figure 23. Multiple Sclerosis (MS) Drugs Market Restraints
Figure 24. Multiple Sclerosis (MS) Drugs Market Trends
Figure 25. Global Multiple Sclerosis (MS) Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Multiple Sclerosis (MS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Multiple Sclerosis (MS) Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Multiple Sclerosis (MS) Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Multiple Sclerosis (MS) Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Multiple Sclerosis (MS) Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Multiple Sclerosis (MS) Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Multiple Sclerosis (MS) Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Multiple Sclerosis (MS) Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Multiple Sclerosis (MS) Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Multiple Sclerosis (MS) Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 40. Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Multiple Sclerosis (MS) Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Multiple Sclerosis (MS) Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Multiple Sclerosis (MS) Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Multiple Sclerosis (MS) Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Multiple Sclerosis (MS) Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Multiple Sclerosis (MS) Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Multiple Sclerosis (MS) Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Multiple Sclerosis (MS) Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Multiple Sclerosis (MS) Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Multiple Sclerosis (MS) Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Multiple Sclerosis (MS) Drugs in 2021
Figure 84. Manufacturing Process Analysis of Multiple Sclerosis (MS) Drugs
Figure 85. Multiple Sclerosis (MS) Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
Keyplayers in Global Multiple Sclerosis (MS) Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Bayer AGBayhill Therapeutics
Biogen Idec
Cinnagen
Daiichi Sankyo
Eli Lilly
Fast Forward Llc
Antisense Therapeutics
Apitope
Five Prime Therapeutics
Genmab
Artielle Immunotherapeutics
Genzyme
Glaxosmithkline
Gw Pharmaceuticals
Innate Immunotherapeutics
Request Sample
Request Discount
